GSK's Financial Performance Highlights

GSK plc has announced its financial results for the first quarter of 2023, revealing a turnover of £6.95 billion. This marks a 2% increase in sales, showcasing the company's resilience in a competitive market.

Further details and analysis on GSK's performance and strategic moves are expected to be released shortly, providing deeper insights into its growth trajectory and future plans.